サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1779737

セルバンキングアウトソーシングの世界市場

Cell Banking Outsourcing

出版日
ページ情報
英文 366 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
セルバンキングアウトソーシングの世界市場
出版日: 2025年07月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 366 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

セルバンキングアウトソーシングの世界市場は2030年までに340億米ドルに達する見込み

2024年に139億米ドルと推定されるセルバンキングアウトソーシングの世界市場は、2024年から2030年にかけてCAGR 16.1%で成長し、2030年には340億米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるマスターセルバンキングは、CAGR18.5%を記録し、分析期間終了時には197億米ドルに達すると予想されます。ワーキングセルバンキングセグメントの成長率は、分析期間中CAGR14.8%と推定されます。

米国市場は38億米ドルと推定、中国はCAGR 21.7%で成長すると予測

米国のセルバンキングアウトソーシング市場は2024年に38億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに76億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは21.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ11.6%と14.6%と予測されています。欧州では、ドイツがCAGR約12.9%で成長すると予測されています。

世界のセルバンキングアウトソーシング市場- 主要動向と促進要因のまとめ

なぜセルバンキングアウトソーシングの需要が増加しているのか？

セルバンキングアウトソーシングの需要が増加しているのは、細胞ベースの治療、再生医療、バイオ医薬品研究の採用が増加しているためです。製薬会社やバイオテクノロジー企業が細胞治療や遺伝子治療、個別化医療、ワクチン製造の開発に注力する中、高品質で保存状態の良い細胞株のニーズは著しく高まっています。細胞バンクサービスをアウトソーシングすることで、研究機関や医薬品開発企業は、コストのかかる社内インフラを維持する負担を負うことなく、細胞株の保存、拡大、管理を行うことができます。

幹細胞治療、モノクローナル抗体、生物製剤の臨床試験の増加は、セルバンキングアウトソーシングの需要をさらに促進しています。細胞ベースの製品開発は複雑であるため、厳格な品質管理、適正製造基準（GMP）の遵守、安全な長期保管が要求され、アウトソーシングはコストの最適化と規制遵守を目指す企業にとって魅力的な選択肢となっています。さらに、個別化医療が進化を続ける中、細胞株の安全性、トレーサビリティ、生存性を確保することが重視されるようになり、信頼性の高い専門的な細胞バンクサービスへのニーズがさらに高まっています。

技術の進歩はどのようにセルバンキングアウトソーシングを改善しているか？

凍結保存、自動バイオプロセス、品質保証技術における革新は、セルバンキングアウトソーシングに革命をもたらし、細胞長期保存の効率と信頼性を向上させています。最も重要な進歩の一つは、高度な凍結保護剤と制御された凍結速度の技術開発であり、これによって保存細胞の生存率と安定性が向上しています。これらの技術革新は、遺伝子ドリフトや細胞劣化のリスクを低減し、研究や治療用途における生物学的サンプルの長期的な利用可能性を保証します。

もうひとつの大きなブレークスルーは、細胞バンク業務における人工知能と自動化の統合です。AIを活用した予測分析やロボットによるハンドリングシステムは、プロセスの一貫性を向上させ、人的ミスを減らし、保管条件を最適化しています。さらに、ブロックチェーン技術が安全なデータ管理とトレーサビリティのために検討されており、細胞バンキング記録の完全な透明性とコンプライアンスを確保しています。クラウドベースのサンプル追跡とデジタル在庫管理システムの採用は、業務効率をさらに高め、顧客が保存している細胞株をリアルタイムで遠隔監視・管理できるようにしています。

セルバンキングアウトソーシング業界の成長を牽引する市場動向は？

再生医療と細胞治療開発への注目の高まりは、セルバンキングアウトソーシング市場を形成する最も影響力のある動向の一つです。幹細胞研究が神経変性疾患、心血管疾患、希少遺伝性疾患の治療のために勢いを増す中、高品質の幹細胞バンキングサービスへの需要が高まっています。バイオ医薬品企業も、モノクローナル抗体や組換えタンパク質を含む生物製剤の大量生産のために、細胞バンクのアウトソーシングへの依存を拡大しています。

市場成長に影響を与えるもう一つの主要動向は、適正製造基準（GMP）と標準化された細胞保存プロトコルの規制重視です。世界の規制当局が細胞治療の製造と保存に関するガイドラインを厳格化する中、アウトソーシング・プロバイダーは業界基準を満たすため、より高いバイオセーフティレベル、GMP準拠施設、高度なモニタリングシステムに投資しています。さらに、バイオテクノロジー研究における国際的な共同研究の増加は、企業が複数の地域にまたがる高品質の細胞株へのアクセスを可能にする集中型細胞バンクサービスへの需要を促進しています。細胞ベースの研究や治療法の急速な拡大に伴い、細胞バンクのアウトソーシングは多くのライフサイエンス企業にとって戦略的に必要なものとなっています。

セルバンキングアウトソーシング市場の将来を形作る主な成長促進要因とは？

セルバンキングアウトソーシング市場の成長は、細胞ベースの治療に対する需要の増加、バイオ保存技術の進歩、バイオ医薬品研究に対する投資の増加など、いくつかの要因によってもたらされます。主な成長要因の1つは、細胞治療や遺伝子治療の臨床試験の拡大であり、開発および規制当局の承認には安全でよく管理された細胞株が必要です。製薬会社や研究機関が再生医療への取り組みを加速させる中、信頼できる細胞バンクパートナーの必要性はますます高まっています。

市場を形成するもう一つの重要な促進要因は、個別化医療と精密治療の採用が増加していることです。細胞ベースの治療がより患者に特化したものになるにつれ、自家および同種保存サービスを含むカスタマイズされた細胞バンキング・ソリューションに対する需要が増加しています。さらに、バイオ医薬品企業と開発・製造受託機関（CDMO）との提携が拡大し、よりスケーラブルでコスト効率の高いアウトソーシング・ソリューションが可能となっています。ライフサイエンス業界が革新を続ける中、セルバンキングアウトソーシングは治療法のブレークスルーを促進し、サンプルの長期的な生存性を確保し、次世代のバイオ医薬品開発をサポートする上で極めて重要な役割を果たすと期待されています。

セグメント

タイプ（マスターセルバンキング、ワーキングセルバンキング、ウイルスセルバンキング）;細胞タイプ（幹細胞、非幹細胞）;フェーズ（バンク保存フェーズ、バンク特性評価および試験フェーズ、バンク準備フェーズ）

調査対象企業の例

  • ATCC（American Type Culture Collection）
  • BioOutsource Ltd.
  • BioReliance Corporation
  • BSL Bioservice
  • CellBank Australia
  • Charles River Laboratories, Inc.
  • Clean Biologics
  • Cordlife Group Limited
  • Covance Inc.
  • Cryo-Cell International Inc.
  • Cryoviva India
  • Eurofins Scientific
  • GBI
  • LifeCell International Pvt. Ltd
  • Lonza Group Ltd.
  • Merck KGaA
  • Paragon Bioservices, Inc.
  • Reliance Life Sciences
  • Sartorius AG
  • SGS Life Sciences

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP29864

Global Cell Banking Outsourcing Market to Reach US$34.0 Billion by 2030

The global market for Cell Banking Outsourcing estimated at US$13.9 Billion in the year 2024, is expected to reach US$34.0 Billion by 2030, growing at a CAGR of 16.1% over the analysis period 2024-2030. Master Cell Banking, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$19.7 Billion by the end of the analysis period. Growth in the Working Cell Banking segment is estimated at 14.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.8 Billion While China is Forecast to Grow at 21.7% CAGR

The Cell Banking Outsourcing market in the U.S. is estimated at US$3.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2030 trailing a CAGR of 21.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.6% and 14.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.9% CAGR.

Global Cell Banking Outsourcing Market - Key Trends & Drivers Summarized

Why Is the Demand for Cell Banking Outsourcing Increasing?

The demand for cell banking outsourcing is increasing due to the rising adoption of cell-based therapies, regenerative medicine, and biopharmaceutical research. As pharmaceutical and biotechnology companies focus on the development of cell and gene therapies, personalized medicine, and vaccine production, the need for high-quality, well-preserved cell lines has grown significantly. Outsourcing cell banking services allows research institutions and drug developers to store, expand, and manage their cell lines without the burden of maintaining costly in-house infrastructure.

The increasing number of clinical trials for stem cell therapies, monoclonal antibodies, and biologics has further fueled the demand for cell banking outsourcing. The complexity of cell-based product development requires stringent quality control, compliance with Good Manufacturing Practices (GMP), and secure long-term storage, making outsourcing an attractive option for companies looking to optimize costs and ensure regulatory compliance. Additionally, as personalized medicine continues to evolve, there is a growing emphasis on ensuring the safety, traceability, and viability of cell lines, further driving the need for reliable and specialized cell banking services.

How Are Technological Advancements Improving Cell Banking Outsourcing?

Innovations in cryopreservation, automated bioprocessing, and quality assurance techniques are revolutionizing cell banking outsourcing, improving the efficiency and reliability of long-term cell storage. One of the most significant advancements is the development of advanced cryoprotectants and controlled-rate freezing technologies, which enhance the viability and stability of stored cells. These innovations reduce the risks of genetic drift and cell degradation, ensuring the long-term usability of biological samples for research and therapeutic applications.

Another major breakthrough is the integration of artificial intelligence and automation in cell banking operations. AI-driven predictive analytics and robotic handling systems are improving process consistency, reducing human error, and optimizing storage conditions. Additionally, blockchain technology is being explored for secure data management and traceability, ensuring full transparency and compliance in cell banking records. The adoption of cloud-based sample tracking and digital inventory management systems is further enhancing operational efficiency, allowing clients to remotely monitor and manage their stored cell lines in real time.

Which Market Trends Are Driving Growth in the Cell Banking Outsourcing Industry?

The increasing focus on regenerative medicine and cell therapy development is one of the most influential trends shaping the cell banking outsourcing market. With stem cell research gaining momentum for treating neurodegenerative disorders, cardiovascular diseases, and rare genetic conditions, demand for high-quality stem cell banking services is growing. Biopharmaceutical companies are also expanding their reliance on outsourced cell banking for large-scale production of biologics, including monoclonal antibodies and recombinant proteins.

Another key trend influencing market growth is the regulatory emphasis on Good Manufacturing Practices and standardized cell preservation protocols. As global regulatory agencies tighten guidelines on cell therapy manufacturing and storage, outsourcing providers are investing in higher biosafety levels, GMP-compliant facilities, and advanced monitoring systems to meet industry standards. Additionally, the rise of international collaborations in biotech research is driving demand for centralized cell banking services, allowing companies to access high-quality cell lines across multiple regions. With the rapid expansion of cell-based research and therapeutics, outsourcing cell banking has become a strategic necessity for many life sciences companies.

What Are the Key Growth Drivers Shaping the Future of the Cell Banking Outsourcing Market?

The growth in the cell banking outsourcing market is driven by several factors, including increasing demand for cell-based therapies, advancements in biopreservation technologies, and rising investments in biopharmaceutical research. One of the primary growth drivers is the expansion of clinical trials for cell and gene therapies, which require secure and well-maintained cell lines for development and regulatory approval. As pharmaceutical companies and research institutions accelerate their efforts in regenerative medicine, the need for reliable cell banking partners is becoming increasingly critical.

Another crucial driver shaping the market is the increasing adoption of personalized medicine and precision therapies. With cell-based treatments becoming more patient-specific, the demand for customized cell banking solutions, including autologous and allogeneic storage services, is on the rise. Additionally, partnerships between biopharmaceutical companies and contract development and manufacturing organizations (CDMOs) are expanding, allowing for more scalable and cost-effective outsourcing solutions. As the life sciences industry continues to innovate, cell banking outsourcing is expected to play a pivotal role in advancing therapeutic breakthroughs, ensuring long-term sample viability, and supporting the next generation of biopharmaceutical development.

SCOPE OF STUDY:

The report analyzes the Cell Banking Outsourcing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking); Cell Type (Stem Cells, Non-stem Cells); Phase (Bank Storage Phase, Bank Characterization and Testing Phase, Bank Preparation Phase)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • ATCC (American Type Culture Collection)
  • BioOutsource Ltd.
  • BioReliance Corporation
  • BSL Bioservice
  • CellBank Australia
  • Charles River Laboratories, Inc.
  • Clean Biologics
  • Cordlife Group Limited
  • Covance Inc.
  • Cryo-Cell International Inc.
  • Cryoviva India
  • Eurofins Scientific
  • GBI
  • LifeCell International Pvt. Ltd
  • Lonza Group Ltd.
  • Merck KGaA
  • Paragon Bioservices, Inc.
  • Reliance Life Sciences
  • Sartorius AG
  • SGS Life Sciences

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Cell Banking Outsourcing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Biologics and Cell-Based Therapies Throws the Spotlight on Cell Banking Outsourcing Solutions
    • Rapid Growth in Cell and Gene Therapy Pipelines Propels the Need for High-Quality Master and Working Cell Banks
    • Increasing Complexity of GMP and Regulatory Compliance Strengthens the Business Case for Outsourced Cell Banking Providers
    • Expansion of Personalized Medicine and Autologous Therapies Drives Custom Cell Bank Storage Requirements
    • Biopharmaceutical Shift Toward Outsourcing Models Fuels Growth in Contract Cell Banking Services
    • Growing Adoption of cGMP-Compliant Facilities Enhances Demand for Specialized Cell Storage and Characterization Services
    • Globalization of Clinical Trials and Manufacturing Operations Expands the Addressable Market for Multi-Site Cell Banking
    • Rising Investment in Stem Cell Research and Regenerative Medicine Creates New Service Demand in Cell Banking Logistics
    • Increased Focus on Supply Chain Risk Mitigation Spurs Interest in Redundant and Disaster-Proof Cell Storage Models
    • Expansion of Allogeneic Cell Therapy Platforms Accelerates Demand for Scalable Banking Infrastructure
    • Stringent Quality Control, Authentication, and Contamination Prevention Standards Drive Laboratory Automation Adoption
    • Emergence of Biobanking-as-a-Service (BaaS) Models Creates Flexible Access for Smaller Biotech Firms
    • Integration of Digital Chain-of-Custody and Sample Tracking Technologies Enhances Service Transparency and Reliability
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Banking Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cell Banking Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Master Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Master Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Master Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Working Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Working Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Working Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Viral Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Viral Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Viral Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Non-stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Non-stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Non-stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bank Storage Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Bank Storage Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Bank Storage Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Bank Characterization & Testing Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Bank Characterization & Testing Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Bank Characterization & Testing Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Bank Preparation Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Bank Preparation Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Bank Preparation Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • JAPAN
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • CHINA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • EUROPE
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Cell Banking Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • FRANCE
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • GERMANY
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Cell Banking Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • INDIA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Cell Banking Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Cell Banking Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • AFRICA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030

IV. COMPETITION